secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeoVax Labs, Inc. (GOVX)
CIK:        0000832489
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001437749-23-033995
Event type: regulatory
Sentiment:  negative
Materiality: 0.78
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeoVax receives Nasdaq delisting notice for bid price under $1; will appeal, plans reverse split
--------------------------------------------------------------------------------

- On Dec 6, 2023, Nasdaq notified GeoVax that its common stock failed to maintain minimum $1 bid price (Nasdaq Rule 5550(a)(2)).
- GeoVax will request a hearing to appeal the delisting; the request stays delisting pending the Panel decision.
- The company plans a Special Stockholders Meeting on Jan 16, 2024 to seek approval for a reverse stock split.
- If the reverse split is approved, GeoVax believes it can regain compliance with the Bid Price Requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832489/000143774923033995/0001437749-23-033995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832489/000143774923033995/govx20231207_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-033995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer